Caption Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1.06 Million - $1.71 Million	86,859 New	86,859 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $336,900 - $587,700	-30,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $401,100 - $533,700	30,000 New	30,000 $488,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $231,399 - $451,905	-11,971 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $147,589 - $256,051	-6,029 Reduced 33.49%	11,971 $296,000

Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $664,530 - $908,480	17,000 Added 1700.0%	18,000 $747,000
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $803,240 - $1.58 Million	-17,200 Reduced 94.51%	1,000 $48,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $788,105 - $1.93 Million	-16,300 Reduced 47.25%	18,200 $1.15 Million
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $1.98 Million - $4.28 Million	34,500 New	34,500 $4.28 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.